Serb Galenika Says It Secures Certificate for Drug Sales in EU

Galenika AD, Serbia’s state-owned drugmaker, said it received a compliance certificate for non-sterile products that allows their sales in the European Union.

Painkillers, anti-coagulants, anti-anxiety and diabetes drugs, exported so far to non-EU neighbors and Russia, will also be offered in Asia and Africa, following the approval by regulator in EU member Slovenia, the company said in an e-mailed statement.

Before it's here, it's on the Bloomberg Terminal.